Polyrizon Ltd. Ordinary Shares (PLRZ) Stock Price

PLRZStock
$10.00+55.76%52W
Market Cap$24.29M
P/E—
PEG Ratio—
Div yield—
Beta0.56

PLRZ Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-21.49%
Price vs S&P 500 (4W)-6.93%
VGM Score63.33

Industry Peers — Surgical & Medical Instruments(142)

SymbolValue ScoreGrowth ScoreMomentum ScoreP/S Ratio (TTM)Revenue Growth (5Y)Gross Margin (TTM)Operating Margin (TTM)Price
PLRZPolyrizon Ltd. Ordinary Shares
——B————$10.00
SYKStryker CorporationCBC4.4x11.8%65.3%21.3%$294.66
MMM3M CompanyCDB3.4x-5.0%39.4%18.4%$164.75
BSXBoston Scientific Corp.CBC3.1x15.2%69.5%19.8%$44.39
BDXBecton, Dickinson and Co.BDA2.5x6.3%46.7%9.6%$191.75
MDLNMedline Inc. Class A common stockCDC1.6x—26.2%6.0%$35.96
RMDResMed Inc.CCB5.9x12.1%61.1%33.4%$238.97
DXCMDexCom, Inc.CBB6.5x19.3%64.3%22.9%$86.04
WSTWest Pharmaceutical Services, Inc.DCA8.5x7.4%36.8%20.4%$384.02
SOLVSolventum CorporationCCB1.8x—54.8%23.9%$85.81
BAXBaxter International Inc.BDB1.1x-0.8%30.7%-2.3%$25.28

About Polyrizon Ltd. Ordinary Shares

Polyrizon Ltd is a clinical-stage biotech company developing nasal gel treatments designed to provide preventative protection against viruses including COVID-19 variants, influenza, and allergens. The company's proprietary platforms—Capture & Contain and Trap & Target—deliver broad-spectrum respiratory pathogen defense.